COMPOSITIONS AND METHODS FOR PREVENTING THE RECURRENCE OF ATRIAL FIBRILLATION AND/OR ATRIAL FLUTTER IN A HUMAN

摘要

Disclosed are compositions and methods for preventing the recurrence of an episode of atrial fibrillation and/or atrial flutter without also inducing torsades de pointes or ventricular fibrillation in a human patient that has previously undergone an episode of atrial fibrillation and/or atrial flutter. Such methods include orally consuming on a daily basis for each of a first plurality of days a single unitary dosage form containing about 50 mg to about 100 mg of vanoxerine, or an equivalent amount of a salt thereof, and one or more pharmaceutically acceptable inert excipients, and then not orally consuming any vanoxerine on a daily basis for a second plurality of days